Metastatic Triple-Negative Breast Carcinoma trials recruiting in California

All Metastatic Triple-Negative Breast Carcinoma trials nationally

Cities in California

Recruiting trials in California

• Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
  NCT05318469 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
  NCT06774027 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
  NCT03606967 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Orange, Sacramento